Biotinylated SARS-CoV-2 Spike RBD Gamma Variant
Catalog Number: B2010504 (25 ug)
Biotinylated SARS-CoV-2 Spike RBD Gamma Variant is a highly pure biotinylated recombinant SARS-CoV-2 RBD from the Gamma Variant lineage (P1, with K417N, E484K, N501Y mutations) expressed in HEK293 cells. This product has been used as molecular component of many serological and antigenic assays for SARS-CoV-2 and its variants. It has also been used in a wide array of other biochemical and immunological applications. Custom bulk amounts of this product are available upon request.
Live enquiry about this product via Text/SMS: 1-858-900-3210.
Product Description
Biotinylated SARS-CoV-2 Spike RBD Gamma Variant
Catalog number: B2010504
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 25 ug
Molecular Weight or Concentration: 27 kDa
Supplied as: Liquid Solution
Applications: molecular component of many serological and antigenic assays for SARS-CoV-2 and its variants
Storage: -20℃
Keywords: Gamma Variant Spike, P1 Spike RBD, P1 RBD, biotin Gamma RBD
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Giovanetti M, Benedetti F, Campisi G, Ciccozzi A, Fabris S, Ceccarelli G,
Tambone V, Caruso A, Angeletti S, Zella D, Ciccozzi M. Evolution patterns of
SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun. 2021
Jan 29;538:88-91.
2: Tang JW, Tambyah PA, Hui DS. Emergence of a new SARS-CoV-2 variant in the UK.
J Infect. 2021 Apr;82(4):e27-e28.
3: Tang JW, Toovey OTR, Harvey KN, Hui DDS. Introduction of the South African
SARS-CoV-2 variant 501Y.V2 into the UK. J Infect. 2021 Apr;82(4):e8-e10.
4: Groves DC, Rowland-Jones SL, Angyal A. The D614G mutations in the SARS-CoV-2
spike protein: Implications for viral infectivity, disease severity and vaccine
design. Biochem Biophys Res Commun. 2021 Jan 29;538:104-107.
5: Priesemann V, Balling R, Brinkmann MM, Ciesek S, Czypionka T, Eckerle I,
Giordano G, Hanson C, Hel Z, Hotulainen P, Klimek P, Nassehi A, Peichl A, Perc
M, Petelos E, Prainsack B, Szczurek E. An action plan for pan-European defence
against new SARS-CoV-2 variants. Lancet. 2021 Feb 6;397(10273):469-470.
6: Blackstone NW, Blackstone SR, Berg AT. Variation and multilevel selection of
SARS-CoV-2. Evolution. 2020 Oct;74(10):2429-2434.
7: The Lancet Respiratory Medicine. Realising the potential of SARS-CoV-2
vaccines-a long shot? Lancet Respir Med. 2021 Feb;9(2):117.
8: Zhang Y, Xi H, Juhas M. Biosensing Detection of the SARS-CoV-2 D614G
Mutation. Trends Genet. 2021 Apr;37(4):299-302.
9: Castillo AE, Parra B, Tapia P, Lagos J, Arata L, Acevedo A, Andrade W, Leal
G, Tambley C, Bustos P, Fasce R, Fernández J. Geographical Distribution of
Genetic Variants and Lineages of SARS-CoV-2 in Chile. Front Public Health. 2020
Sep 22;8:562615.
10: Kannan S, Shaik Syed Ali P, Sheeza A. Evolving biothreat of variant SARS-
CoV-2 – molecular properties, virulence and epidemiology. Eur Rev Med Pharmacol
Sci. 2021 Jun;25(12):4405-4412.
Products Related to Biotinylated SARS-CoV-2 Spike RBD Gamma Variant : SARS-CoV-2
Additional Information
| Weight | 48 oz |
|---|---|
| Dimensions | 8 × 8 × 8 in |